Atlas Trials

The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients

Clinical trial NCT05632133 · COMPLETED

Trial details

NCT number
NCT05632133
Sponsor
Kafrelsheikh University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Effect of DrugMigraine Disorders
Start date
2022-06-01
Primary completion
2023-08-09
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.